Translation News and Research

RSS

WIN Consortium proposes unique alliance to fight cancer

WIN Consortium proposes a unique alliance to fight cancer and invites you to join the 3rd annual symposium: Gateways to efficacy of cancer diagnostics and therapeutics to be held on 6th to 8th of July at the Palais des Congrès in Paris, France.

10 Feb 2011

BBSRC, EMBL-EBI applaud funding allocation for European Life-science Infrastructure for Biological Information

The Biotechnology and Biological Sciences Research Council (BBSRC) and the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) welcome news that funding has been earmarked from the UK's Large Facilities Capital Fund for ELIXIR - the European Life-science Infrastructure for Biological Information - as announced today (09 February 2011).

9 Feb 2011

AcademyHealth recognizes military health research study with 2011 HSR Impact Award

AcademyHealth today recognized research that improves access to behavioral health care for returning U.S. service members with the 2011 Health Services Research Impact Award.

9 Feb 2011

DENTSPLY 2010 net sales increase 2.9% to record $2.221 billion

DENTSPLY International Inc. today announced sales and earnings for the three months and year ended December 31, 2010.

9 Feb 2011

Life Sciences Discovery Fund announces nearly $600,000 in awards

The Life Sciences Discovery Fund (LSDF) today announced nearly $600,000 in awards to support commercial development of technologies to improve the diagnosis and management of major health conditions.

9 Feb 2011

Rush University director receives first $50,000 AACN Impact Research Grant

The American Association of Critical-Care Nurses recently awarded its first $50,000 AACN Impact Research Grant to Ruth Kleinpell, PhD, RN-CS, FAAN, director, Center for Clinical Research, Rush University Medical Center, Chicago, and professor, Rush University College of Nursing.

7 Feb 2011

NCR fourth-quarter revenue increases 5% to $1.4 billion

NCR Corporation reported financial results today for the three months ended December 31, 2010. Reported revenue of $1.4 billion increased 5 percent from the fourth quarter of 2009 on both an actual and constant currency basis.

3 Feb 2011

Invacare 2010 adjusted earnings per share increase 16% to $1.84

Invacare Corporation today announced its financial results for the quarter and year ended December 31, 2010 and provided guidance for 2011.

3 Feb 2011

Thermo Fisher Scientific 2010 revenues increase 7% to $10.79 billion

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2010.

From Thermo Fisher Scientific Inc. 2 Feb 2011

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

A targeted delivery combination selectively crosses the tight barrier that protects the brain from the bloodstream to home in on and bind to brain tumors, a research team led by scientists from The University of Texas MD Anderson Cancer Center reported in the January issue of the Journal of Clinical Investigation.

2 Feb 2011

Fox Chase announces posting of clinical outcomes data to its website for patient use

Fox Chase Cancer Center, one of the nation's leading cancer research and treatment institutions, today announced the posting of clinical outcomes data to its website as a tool to assist newly-diagnosed patients in deciding where to seek cancer care.

1 Feb 2011

Researchers discover 'common set of dysregulated miRNAs in murine lupus models'

Potentially impacting future diagnosis and treatment of lupus, an immune illness affecting more than 5 million people worldwide, researchers at the Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech have likely uncovered where the breakdown in the body's lymphocyte molecular regulatory machinery is occurring.

1 Feb 2011

Avantra Biosciences selects TGen Drug Development for new biomarker quantitation platform

Avantra Biosciences today announced the selection of TGen Drug Development as a key test site for Avantra's new biomarker quantitation platform.

1 Feb 2011

Eurogentec, ImaginAb announce collaboration to produce engineered antibody fragments

ImaginAb, and Eurogentec S.A. announce a development collaboration to establish a novel system for producing engineered antibody fragments. The two companies will produce ImaginAb's optimized antibody fragments with Eurogentec's high-performance Pichia pastoris expression system.

1 Feb 2011

Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of preventive care

Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital Association annual survey.

29 Jan 2011

Zimmer fourth quarter net sales increase 2.5% to $1.13 billion

Zimmer Holdings, Inc. today reported financial results for the quarter and year ended December 31, 2010. The Company reported fourth quarter net sales of $1.13 billion, an increase of 2.5% reported and 3.0% constant currency over the fourth quarter of 2009.

27 Jan 2011

GE's Pathology Imaging Centre of Excellence receives HTX investment under Ontario Flagship Program

HTX announced today an agreement to establish GE's first global Pathology Imaging Centre of Excellence in Toronto, Ontario. GE Healthcare and its digital pathology joint venture, Omnyx™, will invest $7.75M along with a $2.25M grant from the Health Technology Exchange (HTX). Planned collaborative research and development (R&D) partnerships will bring an additional $7.2M, for a total investment of $17.2M over the next 3 years.

27 Jan 2011

Waters fourth quarter sales increase 13% to $484 million

Waters Corporation reported fourth quarter 2010 sales of $484 million, an increase of 13% from sales of $429 million in the fourth quarter of 2009. In the quarter, foreign currency translation was about neutral to sales growth. On a GAAP basis, earnings per diluted share (E.P.S.) for the fourth quarter were $1.36 compared to $1.08 for the fourth quarter of 2009.

25 Jan 2011

SNM commends FDA Advisory Committee recommendation for florbetapir approval

The Society of Nuclear Medicine (SNM) commends the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee on its recent recommendation for conditional approval of a new imaging agent, florbetapir.

25 Jan 2011

Failure to use research evidence leads to inefficiencies, reduced quality of life, says Dr. Sharon

Health care systems around the world are failing to use evidence obtained through research when making decisions, causing inefficiencies and reduced quantity and quality of life, according to a leading expert in the field of "knowledge translation."

20 Jan 2011

Translation News and Research

WIN Consortium proposes unique alliance to fight cancer

BBSRC, EMBL-EBI applaud funding allocation for European Life-science Infrastructure for Biological Information

AcademyHealth recognizes military health research study with 2011 HSR Impact Award

DENTSPLY 2010 net sales increase 2.9% to record $2.221 billion

Life Sciences Discovery Fund announces nearly $600,000 in awards

Rush University director receives first $50,000 AACN Impact Research Grant

NCR fourth-quarter revenue increases 5% to $1.4 billion

Invacare 2010 adjusted earnings per share increase 16% to $1.84

Thermo Fisher Scientific 2010 revenues increase 7% to $10.79 billion

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

Fox Chase announces posting of clinical outcomes data to its website for patient use

Researchers discover 'common set of dysregulated miRNAs in murine lupus models'

Avantra Biosciences selects TGen Drug Development for new biomarker quantitation platform

Eurogentec, ImaginAb announce collaboration to produce engineered antibody fragments

Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of preventive care

Zimmer fourth quarter net sales increase 2.5% to $1.13 billion

GE's Pathology Imaging Centre of Excellence receives HTX investment under Ontario Flagship Program

Waters fourth quarter sales increase 13% to $484 million

SNM commends FDA Advisory Committee recommendation for florbetapir approval

Failure to use research evidence leads to inefficiencies, reduced quality of life, says Dr. Sharon

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News